Incress Pharmaceuticals (Yingkou) Co., Ltd.

Pharmacokinetic parameters were used as the primary endpoint evaluation indicators to compare the pharmacokinetic behaviors of the test preparation, quetiapine fumarate orally disintegrating tablets provided by Beijing Kaiyi Pharmaceutical Technology Development Co., Ltd., and the reference preparation, quetiapine fumarate tablets (AstraZeneca UK Limited, trade name: Seroquel®), in healthy subjects after oral administration in the fasting/postprandial state, to evaluate the bioequivalence of the two preparations and observe the safety of the two preparations in healthy subjects.